Febuxostat Tablets
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-26-R-0012
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a solicitation for a national requirements contract for Febuxostat Tablets (40 MG and 80 MG in 30-count bottles) with a projected solicitation release in June 2026. This is an unrestricted, fully competitive acquisition with no set-aside.
The contract will be firm-fixed price, requirements type with a one-year base and four one-year options. Performance will supply Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through DLA and VA prime vendor programs. Annual usage estimates will be provided in the solicitation schedule. As a commercial item, the acquisition will use FAR Part 12 procedures. All sources may submit proposals.
The solicitation will post to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov. Interested parties should contact Christopher Newman at (445) 737-7371 or Christopher.Newman@dla.mil for questions and are advised to enable automated notifications for pre-solicitation and solicitation changes on this website. DLA reserves the right to issue the solicitation before or after the June 2026 projected date.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Febuxostat Tablets. Procurement details follow.
Febuxostat Tablets: 40 MG and 80 MG Tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Christopher Newman at (445) 737-7371 or Christopher.Newman@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is June of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Febuxostat Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Prednisolone 1% Ophthalmic Solution | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity